Exploit
发表于 2025-3-26 23:45:14
http://reply.papertrans.cn/23/2235/223425/223425_31.png
META
发表于 2025-3-27 03:19:47
http://reply.papertrans.cn/23/2235/223425/223425_32.png
Little
发表于 2025-3-27 05:46:47
http://image.papertrans.cn/c/image/223425.jpg
Expiration
发表于 2025-3-27 13:01:49
https://doi.org/10.1007/978-3-642-56781-0way for over a decade. While the number of new cases each year has gone down globally, the goal of total disease elimination has roughly been achieved. The parameters (poverty, malnutrition, poor sanitation and health care, climate change, globalization, etc.) that drive the endemics of the disease
集合
发表于 2025-3-27 14:14:22
Pathologie der weiblichen Genitalorgane IIIeatest burden of visceral leishmaniasis (VL)—East Africa (South Sudan, Sudan and Ethiopia) and South Asia (India, Bangladesh and Nepal) between April 2014 and June 2019. The overall aim of the KalaCORE programme was to sustainably reduce the economic and health impact of VL in the two regions. KalaC
outer-ear
发表于 2025-3-27 20:07:42
Zervix: Physiologie und Anatomie,e disease, with a worldwide prevalence of 12 million cases, is endemic in tropical and subtropical countries and affects mainly the poor in remote areas. Being a vector-borne disease, the parasite is transmitted through the bite of . female sand fly resulting in a spectrum of diseases with symptoms
莎草
发表于 2025-3-27 22:58:53
http://reply.papertrans.cn/23/2235/223425/223425_37.png
dapper
发表于 2025-3-28 05:00:00
http://reply.papertrans.cn/23/2235/223425/223425_38.png
recede
发表于 2025-3-28 09:29:38
,Zur Geschichte der Gynäkopathologie,hmaniasis. Timely diagnosis and treatment of PKDL cases are paramount in achieving sustained kala-azar elimination. Diagnosis of PKDL remains a major challenge due to sparse parasite loads, especially in macular cases. A substantial number of PKDL cases are misdiagnosed at primary health centers. Co
灌输
发表于 2025-3-28 12:57:52
Zervix: Physiologie und Anatomie,n lesions to mucocutaneous leishmaniasis (MCL) involving the mucous membrane to systemic visceral leishmaniasis (VL). The disease outcome is mediated by the parasite determinants along with the host immunity elicited by the infecting species involved. . or . is responsible for VL; the ., . or . caus